8
Oct
2024

SunBio Inc.

Exhibitor at CPHI Milan 2024 stand 4D38, API
About Us

SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medical devices based on our proprietary technologies of pegylation.SunBio offers a variety of PEG product, or activated PEG derivatives, that are crucial ingredients in the art of PEGylation. The EMA-approved GMP manufacturing facility for manufacturing of PEG products is in operation.SunBio’s biosimilar product, PEG-filgrastim, has been marketed in EU (Pelgraz™) and Canada (Lapelga™) since 2018 and in India (NeuPEG™) since 2008.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2024
    On CPHI since
  • 3
    Certificates
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
View company profile
Contact info
  • +82 1049510042
  • Website
  • 95 Sanbon-ro, Gunpo-si, Gyeonggi-do, 15849, Gunpo City, Gyen, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4D38, API